Fentanyl transdermal - Kindeva Drug Delivery/Purdue Pharma
Latest Information Update: 31 Dec 2021
At a glance
- Originator 3M Drug Delivery Systems; Purdue Pharma
- Developer Kindeva Drug Delivery; Purdue Pharma
- Class Amides; Benzene derivatives; General anaesthetics; Opioid analgesics; Piperidines; Small molecules
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 23 Dec 2002 No development reported - Phase-I for Pain in USA (Transdermal)
- 23 Feb 2001 Phase-I clinical trials for Pain in USA (Transdermal)